Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Efficacy and safety of durcabtagene autoleucel in a phase 1 trial for patients with relapsed/refractory multiple myeloma.
Journal: Science translational medicine
Published: May 27, 2026
Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 03, 2025
Early versus late infectious complications following chimeric antigen receptor-modified T-cell therapy.
Journal: Leukemia & lymphoma
Published: December 20, 2024
Durable response to CAR T is associated with elevated activation and clonotypic expansion of the cytotoxic native T cell repertoire.
Journal: Nature communications
Published: July 18, 2024
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia.
Journal: Blood
Published: June 17, 2024
High CD34-positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft-versus-host disease or mortality.
Journal: Transfusion
Published: January 08, 2024
Clonal myeloid disorders following CAR T-cell therapy.
Journal: Annals of hematology
Published: July 06, 2023
Personalized tumor vaccine for pancreatic cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: February 23, 2022
Vaccination as Immunotherapy in Hematologic Malignancies.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 12, 2021
Last Updated: 09/26/2026